Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Lara Jehi, MD, completed her Neurology Residency and Clinical Neurophysiology Fellowship training at the Cleveland Clinic. She is board-certified in neurology and clinical neurophysiology, and has many clinical interests, including medical and surgical treatment of epilepsy.
Dr Jehi's current roles include both administrative and academic responsibilities. Within the Epilepsy Center, she serves as the Research Director and Head of the Outcomes Research Program, as well as the Quality Improvement Officer. At an institutional level, Dr Jehi is the Associate Director of the Clinical Research Unit supported by a Clinical and Translational Science Award from the NIH. At the level of the American Epilepsy Society, her roles include acting as a contributing editor to Epilepsy Currents, a member of the Annual Course Planning Committee as well as the CME review subcommittee. She also has some national service responsibilities, including being on the board of trustees of Cleveland's Epilepsy Association chapter.
Dr Jehi's academic interests have always focused on outcomes research in epilepsy, advancing the field to improve the selection of adequate epilepsy surgery candidates and developing mechanistic hypotheses to allow a better understanding of the process of seizure recurrence after surgery. Past awards include the American Academy of Neurology's Contemporary Clinical Issues Plenary Session award in 2003, the Young Investigator Award by the American Epilepsy Society in 2005, and the Best Doctors in America recognition in 2013.
As an invited lecturer at national and international medical meetings, Dr Jehi authored several scientific papers in prestigious peer reviewed journals such as Annals of Neurology, Brain, Neurology, and Epilepsia. She has served as a reviewer for these and several other journals, authored multiple book chapters, and served as an examiner in the national certification examinations for the board of clinical neurophysiology.
Adult and geriatric epilepsy, surgical evaluation of intractable epilepsy, clinical trials, outcomes research
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/3/2015, Dr. Jehi has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.